Mindfulness in migraine: A narrative review
- PMID: 31933391
- PMCID: PMC7213534
- DOI: 10.1080/14737175.2020.1715212
Mindfulness in migraine: A narrative review
Abstract
Introduction: Migraine is the second leading cause of disability worldwide, yet many patients are unable to tolerate, benefit from, or afford pharmacological treatment options. Non-pharmacological migraine therapies exist, especially to reduce opioid use, which represents a significant unmet need. Mindfulness-based interventions (MBI) have potential as a non-pharmacological treatment for migraine, primarily through the development of flexible attentional capacity across sensory, cognitive, and emotional experiences.Areas covered: The authors review efficacy and potential mechanisms of MBIs for migraine, including mindfulness-based stress reduction (MBSR) and mindfulness-based cognitive therapy (MBCT).Expert opinion: While most mindfulness research studies for migraine to date have been pilot trials, which are small and/or lacked rigor, initial evidence suggests there may be improvements in overall headache-related disability and psychological well-being. Many research questions remain to help target the treatment to patients most likely to benefit, including the ideal dosage, duration, delivery method, responder characteristics, and potential mechanisms and biomarkers. A realistic understanding of these factors is important for patients, providers, and the media. Mindfulness will not 'cure' migraine; however, mindfulness may be an important tool as part of a comprehensive treatment approach to help patients 'mindfully' engage in valued life activities.
Keywords: Complementary and alternative medicine; integrative medicine; meditation; migraine; mind-body medicine; mindfulness; mindfulness-based cognitive therapy; mindfulness-based intervention; mindfulness-based stress reduction.
Figures
Comment in
-
Mindfulness as one component of an integrative approach to migraine treatment in clinical practice: companion editorial.Expert Rev Neurother. 2020 Mar;20(3):199-202. doi: 10.1080/14737175.2020.1724783. Epub 2020 Feb 12. Expert Rev Neurother. 2020. PMID: 32000542 Free PMC article. No abstract available.
References
-
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). 2018. November 10;392(10159):1789–1858. - PMC - PubMed
-
- Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007. January 30;68(5):343–9. - PubMed
-
- Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, Burden, and Comorbidity. Neurologic clinics. 2019. Nov;37(4):631–649. - PubMed
-
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia : an international journal of headache. 2018. January;38(1):1–211. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical